PUMA BIOTECHNOLOGY, INC.·4

Dec 6, 6:55 PM ET

Wong Alvin F 4

4 · PUMA BIOTECHNOLOGY, INC. · Filed Dec 6, 2021

Insider Transaction Report

Form 4
Period: 2021-12-02
Wong Alvin F
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2021-12-02$2.91/sh1,131$3,29417,152 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4 - WONG